DSGN Logo

Design Therapeutics, Inc. (DSGN) 

NASDAQ
Market Cap
$314.53M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
297 of 963
Rank in Industry
177 of 552

Largest Insider Buys in Sector

DSGN Stock Price History Chart

DSGN Stock Performance

About Design Therapeutics, Inc.

Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.

Insider Activity of Design Therapeutics, Inc.

Over the last 12 months, insiders at Design Therapeutics, Inc. have bought $104,604 and sold $3.46M worth of Design Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Design Therapeutics, Inc. have bought $15.55M and sold $1.87M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Schmid John P. (director) — $199,477. Berger Heather A. (director) — $4,866.

The last purchase of 17,809 shares for transaction amount of $66,606 was made by Schmid John P. (director) on 2024‑03‑25.

List of Insider Buy and Sell Transactions, Design Therapeutics, Inc.

2024-08-09Saledirector
814,874
1.4426%
$4.25$3.46M+29.95%
2024-03-25Purchasedirector
17,809
0.0318%
$3.74$66,606+24.87%
2024-03-25Purchasedirector
1,300
0.0023%
$3.74$4,866+24.87%
2024-03-22Purchasedirector
9,156
0.0156%
$3.62$33,133+21.93%
2023-09-29Purchasedirector
21,000
0.0373%
$2.35$49,287+21.61%
2023-08-29Purchasedirector
1.96M
3.6838%
$2.44$4.78M+15.58%
2023-08-29Purchasedirector
12,000
0.0213%
$2.31$27,670+15.58%
2023-08-28Purchasedirector
275,000
0.48%
$2.15$591,250+21.14%
2022-12-20Purchasedirector
40,000
0.0725%
$8.14$325,432-27.73%
2022-12-20Purchasedirector
40,000
0.0725%
$8.14$325,432-27.73%
2022-12-20PurchasePresident and CEO
6,300
0.0118%
$8.38$52,763-27.73%
2022-12-19Purchasedirector
360,000
0.6698%
$8.63$3.11M-29.65%
2022-12-19Purchasedirector
360,000
0.6698%
$8.63$3.11M-29.65%
2022-12-19PurchasePresident and CEO
1,150
0.0021%
$8.47$9,741-29.65%
2022-12-16Purchasedirector
500,000
0.8485%
$8.28$4.14M-32.42%
2022-12-16Purchasedirector
500,000
0.8485%
$8.28$4.14M-32.42%
2022-12-09Purchasedirector
15,000
0.0273%
$7.96$119,426-22.01%
2022-03-21Purchase
25,000
0.0461%
$18.99$474,680-22.95%
2022-03-18Sale
13,200
0.0246%
$20.34$268,488-26.91%
2021-08-31Purchasedirector
40,000
0.0713%
$15.45$618,000+0.60%

Insider Historical Profitability

<0.0001%
Schmid John P.director
26965
0.0476%
$5.5620
Berger Heather A.director
1300
0.0023%
$5.5610
William Arsanidirector
0
0%
$5.5651<0.0001%
George Simeondirector
6526476
11.5266%
$5.5640<0.0001%
SR One Capital Fund I Aggregator LPdirector
6526476
11.5266%
$5.5640<0.0001%
Cormorant Asset Management, LP
5114844
9.0335%
$5.5610<0.0001%
Xu Stella
4155405
7.339%
$5.5611<0.0001%
LAPPE RODNEY Wdirector
133024
0.2349%
$5.5630<0.0001%
Siffert Joao MDPresident and CEO
132619
0.2342%
$5.5620<0.0001%
Shah PratikExecutive Chairperson
25000
0.0442%
$5.5610<0.0001%
Prasad Deepadirector
23806
0.042%
$5.5610
Thacker JustinVice President, Finance
17500
0.0309%
$5.5610<0.0001%
Jeffries SeanChief Operating Officer
3050
0.0054%
$5.5610<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Sr One Capital Management Lp$26.3M11.556.53M0%+$07.22
Logos Global Management Lp$20.28M8.915.03M0%+$02.19
BlackRock$9.16M4.032.27M-4.46%-$427,385.50<0.0001
Baker Bros Advisors LP$6.7M2.941.66M+10.81%+$653,343.640.05
Tang Capital Management, LLC$5.97M2.621.48M+0.02%+$1,209.000.02
The Vanguard Group$5.18M2.281.29M+28.96%+$1.16M<0.0001
Almitas Capital LLC$4.14M1.821.03M0%+$02.17
Bml Capital Management Llc$3.54M1.56879,478-14.57%-$604,499.942.72
Citadel Advisors LLC$3.53M1.55874,777-52.26%-$3.86M<0.01
State Street$2.82M1.24698,986+0.54%+$15,160.86<0.0001
Geode Capital Management$2.76M1.21683,898+3.19%+$85,258.08<0.0001
Point72 Asset Management$2.39M1.05593,516New+$2.39M<0.01
Goldman Sachs$2.04M0.9506,256-50.55%-$2.09M<0.0001
Jacobs Levy Equity Management$2.02M0.89502,020-8.58%-$189,804.980.01
Millennium Management LLC$1.95M0.86484,468+15.33%+$259,552.14<0.01
Morgan Stanley$1.93M0.85478,092-12.03%-$263,517.84<0.0001
Renaissance Technologies$1.83M0.8453,400-30.12%-$787,374.94<0.01
D. E. Shaw & Co.$1.8M0.79446,190+53.53%+$626,914.96<0.01
Two Sigma$1.7M0.75422,035-1.43%-$24,728.08<0.01
Two Sigma Advisers LP$1.63M0.72404,000-30.94%-$729,430.00<0.01
Acadian Asset Management$1.63M0.71403,546+123.27%+$897,191.710.01
Northern Trust$1.44M0.63357,284-4.2%-$63,041.31<0.0001
Assenagon Asset Management S.A.$1.4M0.62347,794+41.83%+$413,345.06<0.01
Prescott Group Capital Management LLC$1.38M0.61343,0000%+$00.16
Gsa Capital Partners Llp$872,000.000.38216,347+199.27%+$580,622.610.07
Wellington Management Company$863,669.000.38214,310New+$863,669.00<0.0001
Walleye Capital$784,041.000.34194,551-46.31%-$676,379.48<0.01
Charles Schwab$722,055.000.32179,170+2.01%+$14,205.75<0.0001
Nuveen$636,757.000.28158,0040%+$0<0.0001
Bridgeway Capital Management$587,977.000.26145,9000%+$00.01
Shay Capital Llc$517,069.000.23128,305New+$517,069.000.08
BNY Mellon$464,425.000.2115,242-4.59%-$22,366.49<0.0001
Opaleye Management Inc$455,543.000.2113,038New+$455,543.000.1
Barclays$358,000.000.1688,908-19.87%-$88,771.18<0.0001
Fidelity Investments$315,714.000.1478,341-0.85%-$2,704.13<0.0001
RhumbLine Advisers$211,374.000.0952,452+3.12%+$6,399.41<0.0001
Ameriprise Financial$203,575.000.0950,515-4.72%-$10,074.98<0.0001
HSBC$196,620.000.0948,789+8.29%+$15,048.05<0.0001
Prelude Capital$195,858.000.0948,6000%+$00.01
Prudential Financial$188,664.000.0846,815+154.22%+$114,451.73<0.0001
Bank of America$182,951.000.0845,397-47.42%-$164,993.21<0.0001
JPMorgan Chase$155,977.000.0738,704-6.2%-$10,300.67<0.0001
AllianceBernstein$151,125.000.0737,5000%+$0<0.0001
Dimensional Fund Advisors$148,526.000.0736,855-11.93%-$20,121.84<0.0001
Squarepoint Ops LLC$146,841.000.0636,437-5.18%-$8,027.75<0.01
UBS$133,123.000.0633,033-34.51%-$70,154.24<0.0001
Ohio Strs$118,000.000.0529,300-59.75%-$175,187.71<0.0001
Deutsche Bank$113,219.000.0528,0940%+$0<0.0001
Ci Private Wealth Llc$108,669.000.0526,965New+$108,669.00<0.0001
Tudor Investment Corp Et Al$102,068.000.0525,327New+$102,068.00<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.